NVO
Novo Nordisk A/S · Healthcare · Drug Manufacturers - General
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -5.6% ·
Aktienfluss -13.2% ·
neue Nettopositionen -5.9%
· Formel
Breite Distribution: sinkende Aktienanzahl und weniger Inhaber
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 347.39K | $13.21M | n/a | n/a |
| Q2 2026 | 132 | 0 | 235.88M | $11.31B | +12 | −13 |
| Q1 2026 | 134 | -8 | 242.80M | $8.91B | +5 | −13 |
| Q4 2025 | 140 | +1 | 228.46M | $11.63B | +3 | −2 |
| Q3 2025 | 19 | -1 | 80.89M | $4.49B | +2 | −3 |
| Q2 2025 | 17 | -1 | 53.30M | $3.68B | +1 | −2 |
| Q1 2025 | 16 | 0 | 43.10M | $3.00B | n/a | n/a |
| Q4 2024 | 16 | -1 | 48.20M | $4.15B | +1 | −2 |
| Q3 2024 | 16 | -1 | 43.13M | $5.09B | +1 | −2 |
| Q2 2024 | 17 | n/a | 46.04M | $6.57B | n/a | n/a |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 13.94M | n/a | $962.22M | 0.1% | n/c | 1 | SEC ↗ ×5 |
| 2 | Fisher Asset Management ✦ | 11.00M | -7.3% | $759.28M | 0.3% | ▼ Trim | 5 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 6.20M | +16.5% | $428.15M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (passiv) | 6.05M | +0.8% | $418.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 4.94M | -27.6% | $340.74M | 0.5% | ▼ Trim | 5 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 4.36M | n/a | $300.80M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 7 | Markel Group ✦ | 2.26M | +5.0% | $155.89M | 1.3% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Two Sigma Investments ✦ | 2.22M | -29.6% | $153.01M | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 9 | Tiger Global Management ✦ | 1.27M | 0.0% | $87.59M | 0.3% | Held | 5 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 396.47K | -76.9% | $27.36M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | Wellington Management ✦ | 260.62K | -74.5% | $17.99M | 0.0% | ▼ Trim | 4 | SEC ↗ ×5 |
| 12 | Capital World Investors ✦ | 215.69K | +3.8% | $14.78M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 125.45K | +102.0% | $8.66M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 14 | Millennium Management ✦ | 35.66K | -96.0% | $2.46M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | Marshall Wace ✦ | 31.20K | +24.2% | $2.15M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | GAMCO Investors ✦ | 4.54K | Neu | $313,627 | 0.0% | New | 1 | SEC ↗ |
| 17 | Baillie Gifford ✦ | 130 | -26.1% | $8,973 | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
„Ihr Gewicht" = Anteil der Position am gemeldeten 13F-Aktienwert des Managers: das Überzeugungsmaß. ✦ = kuratorisch betreuter Manager.
Neue Käufer
| GAMCO Investors | $313,627 | 0.0% |
Ausgestiegen
| D. E. Shaw & Co. | $179.33M | war 0.2% |
| Arrowstreet Capital | $745,647 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1 Inhaber, 1.21M Anteile, $43.09M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten: gemeinsame Eigentümerzahlen, keine fundamentalen Beziehungen.